SKT Investment Firm 'Nanox' Successfully Listed on US Nasdaq

[Asia Economy Reporter Seulgina Jo] SK Telecom's proactive investment in the next-generation medical equipment technology company ‘Nanox’ successfully led to its listing on the US Nasdaq on the 21st.

SK Telecom is the second-largest shareholder after Nanox's related parties (founders and top executives) and is actively involved in management and global business expansion. In June 2019 and again in June this year, SK Telecom strategically invested a total of $23 million (approximately 27.3 billion KRW), securing a total of 2,607,466 shares of Nanox.

The Israeli company ‘Nanox’ is promoting the commercialization of the medical device ‘Nanox.Arc,’ which, based on semiconductor-based digital X-ray technology, offers superior price and performance compared to existing X-ray equipment. The company’s technological capabilities were recognized, enabling it to successfully list on Nasdaq as an ‘Emerging Growth Company.’

SK Telecom discovered ‘Nanox’ last year while seeking collaboration with global semiconductor startups and proceeded with investment after multiple validations of its technology. Going forward, SK Telecom plans to build Nanox’s core semiconductor manufacturing plant (FAB) in Korea and pursue various joint projects utilizing 5G and AI technologies.

SK Telecom stated, “Nanox’s technology and potential are highly valued overseas as well, resulting in an unusually rapid Nasdaq IPO,” and added, “Together with Nanox, we will create a representative innovation case of the post-COVID era by integrating next-generation medical technology with 5G and AI.”

Meanwhile, Nanox’s stock price rose 20.56% on the 21st, closing at $21.7 from the listing price of $18.

This content was produced with the assistance of AI translation services.